๐ฌ Multiomics meets 3D tumor models in drug discovery
Researchers are now integrating multiomics data with patient-specific 3D tumoroid models for advanced drug discovery. This innovative approach is being developed by a collaborative team across several leading cancer research institutes. The project is currently in its pilot phase, aiming for major milestones by Q4 2024. This fusion of biological data and high-fidelity modeling promises more personalized cancer treatments. Future steps involve rigorous in-vitro and in-vivo validation of the resulting drug candidates.